BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 8, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 5, 2019

View Archived Issues

I-Mab and BCT to collaborate on arginine depletion therapy

Read More

Aprea initiates phase III study of APR-246 and azacitidine for TP53 mutant MDS

Read More

Phase II trial investigates TIMP-GLIA in subjects with celiac disease

Read More

EBV and cancer linked in more ways than one

Read More

NanoViricides advances shingles drug candidate NV-HHV-101 into IND-enabling studies

Read More

Separating latent from dead HIV genomes

Read More

TNF levels do not predict TNF blocker success

Read More

VU-6001376 demonstrates efficacy in preclinical model of Parkinson's disease

Read More

Evidence of molecular mechanism of DZ-2002 on glomerulonephritis in SLE

Read More

IgG4:IgG RNA ratio as a marker of disease activity in granulomatosis with polyangiitis

Read More

GlaxoSmithKline initiates phase I study of GSK-3844766A vaccine

Read More

First patient enrolled in phase II study of tolperisone for acute muscle spasms

Read More

SHCBP1 unveiled as therapeutic target in gastric cancer

Read More

High rate of response seen with Cytori Cell Therapy for perianal fistula in Crohn's disease

Read More

Ideaya Biosciences presents aryl hydrocarbon receptor modulators

Read More

Merck KGaA discloses new TLR7 and TLR8 antagonists

Read More

Neurotrope enters CRADA with NCI to study bryostatin-1 in leukemia and B-cell lymphoma

Read More

Guerbet identifies new compounds for liver cancer

Read More

Pivotal ICARIA-MM study of isatuximab in relapsed/refractory multiple myeloma meets primary endpoint

Read More

Phase Ib data support expansion of indication for BioXcel's BXCL-501

Read More

Theralase reports further phase Ib data on TLD-1433 in nonmuscle invasive bladder cancer

Read More

Atatuerk Ueniversitesi describes new compounds for cancer

Read More

ICMR and collaborators identify new PTP-1B inhibitors

Read More

FDA accepts IND for Spero's phase III study of SPR-994 for cUTI

Read More

SBRI funding supports Amprologix's development of epidermicin NI-01

Read More

NIH grant supports Syntrix in development of SX-682 for MDS

Read More

Reduction of BACE1 protein levels by MMP-13 inhibition shows therapeutic potential for AD in mice

Read More

Novel chimeric DNA vaccine shows prophylactic and therapeutic effect against cervical cancer in mice

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 8, 2026.
  • Hengrui discovers new Nav1.8 blockers

    BioWorld Science
    Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
  • Cancer and blood cells

    Hematopoietic stem cell research points to leukemia’s early roots

    BioWorld Science
    Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 7, 2026
  • 3D illustration of antibodies

    Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis

    BioWorld Science
    Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing